#DidYouKnow Women tend to take longer to make a decision, but are more likely to stick with the decision.
MRCCC Siloam Hospitals Semanggi (MRCCC)
Cancer is one of the leading causes of death in many South East Asian countries and in the world. Nearly 8 million (13% of all deaths) people die worldwide annually as a result of cancer. The top five most common types are lung, breast, colorectal stomach and liver cancers. Worldwide over 10 million people are diagnosed with cancer every year and over 70% of this is in low or middle-income countries like Indonesia. In Indonesia, the prevalence rate of this disease is increasing rapidly and is predicted to be one of the leading causes of death after cardiovascular diseases. Though there is no accurate national prevalence, morbidity and mortality data related to cancer, it is estimated that there will be around 170-190 per 100,000 people of new cancer cases annually, i.e. about 450,000 new cancer patients every year.
Unfortunately, the availability and accessibility to comprehensive cancer treatment services in this country is not sufficient. This has led to a substantial number of Indonesians seeking medical advice and treatment in other countries such as Singapore, China, Australia and the United States. It is estimated that the number of patients going abroad for medical treatment is over 600,000 people every year, and spending just over US$1.2 billion in foreign expenditure.
Now, MRCCC's specialists are at hand to manage the most common cancers found in Indonesia: Cervical, Breast, Liver, Lung, Nasopharynx, Skin, Colorectal, Leukemia, Lymphoma Malginum and Ovarium. Given the rising high incidence of Hepatitis B and C in Indonesia, MRCCC has a dedicated Liver GI Centre to facilitate early detection and accurate prognosis so that you can be given the appropriate care and treatment.
MRCCC will also be one of the first in Indonesia to run an integrated computerized and digital information system linking imaging, laboratory, pharmacy and hospital IT services. This will speed up the efficiency and accuracy of service provision with the aim of not only improving the experience to the patient but also facilitating early diagnoses and improved outcomes. Modern IT systems will also help foster research and collaboration within the MRCCC. Siloam Hospitals has invested heavily in recruiting and training Oncology specialists who will be the backbone of the Cancer Centre. They have been sent to countries such as Australia, China, India and Singapore to be trained on latest medical techniques and equipment.
MRCCC was commissioned in mid December 2010, involving the simulation of operations to ensure that all the sophisticated state-of-the-art equipment and systems in this complex hospital are integrated for safe and quality delivery of care. A quality of care and service that has never been accessible to a vast majority of Indonesians.